Effect of 5,7-dihydroxytryptamine on the development of tolerance to ethanol

Psychopharmacology (Berl). 1980 Feb;67(2):143-6. doi: 10.1007/BF00431969.

Abstract

5,7-Dihydroxytryptamine (5,7-DHT) or the vehicle was administered once into both lateral ventricles of the rat. Desmethylimipramine (DMI) was administered IP prior to the intraventricular injection of 5,7-DHT to prevent the destruction of norepinephrine (NE) terminals. Following recovery from surgery, ethanol (5 g/kg, PO) or isocaloric sucrose was given daily for 25 days. Tests at 5-day intervals showed that chronic ethanol treatment produced tolerance to the motor impairment on the moving belt test and to hypothermic effects of ethanol. The 5,7-DHT treatment did not alter either the motor impairment or hypothermia produced by the initial dose of ethanol. However, 5,7-DHT treatment produced a 75% depletion of brain serotonin (5-HT) without altering NE concentration and retarded the development of tolerance to ethanol in both measurements. This study with a specific central depletor of 5-HT, without alteration in NE concentration, extends and supports our hypothesis that brain 5-HT modulates the development of tolerance to ethanol.

MeSH terms

  • 5,7-Dihydroxytryptamine / administration & dosage
  • 5,7-Dihydroxytryptamine / pharmacology*
  • Animals
  • Body Temperature / drug effects
  • Desipramine / pharmacology
  • Dihydroxytryptamines / pharmacology*
  • Drug Interactions
  • Drug Tolerance
  • Ethanol / pharmacology*
  • Injections, Intraventricular
  • Male
  • Motor Activity / drug effects
  • Norepinephrine / metabolism
  • Rats
  • Serotonin / metabolism

Substances

  • Dihydroxytryptamines
  • 5,7-Dihydroxytryptamine
  • Serotonin
  • Ethanol
  • Desipramine
  • Norepinephrine